Skip to content

The BGCS website uses cookies to give you the best possible experience. By continuing, we will assume you are happy to receive all cookies on the website. More information on cookies can be found on our privacy page.

Sentinel Consensus Document for Vulval, Endometrial and Cervical Cancer BGCS

13 May 2019

The BGCS is pleased to present these consensus statements on the use of sentinel lymph node staging in the management of cervical, endometrial and vulval malignancies. The statement reflects an analysis of the published evidence assessing this methodology combined with review of expert opinion and experience, and involved a formal "Delphi" process to achieve specialist consensus. The statement will inform forthcoming BGCS clinical guidelines for the management of these diseases, and we hope that they will also inform future NHS England Specialist Commissioning specifications and commissioning guidelines from the NHS in Scotland, Wales and Northern Ireland.

We would like to thank the specialist working group for the time and effort which went into developing these consensus statements, and particularly Christina Fotopoulou, Chair of the BGCS Guidelines Subgroup for leading the process.

Andy Nordin, BGCS President
Sudha Sundar, BGCS President-Elect
May 2019

View document